NeOnc Technologies Holdings is trading at $2.56, down 6.23%, with no clear company-specific announcement identified to explain the October 13 decline.
- The companyβs investor-relations page showed September 17 as its latest release.
- The supplied sector context shows XBI down 2.01%; reporting describes recent biotech weakness amid disappointing trial readouts, higher rates and investor caution.
- The sector decline may be contributing, but does not establish the cause of NeOncβs larger move.